Synthes
-
Biologics
Families Sue Synthes Over Bone Cement
The families of two patients who died during surgery that used an unapproved Synthes, Inc. bone cement are suing. A…
Read More » -
Extremities
Synthes gets warning letter over complaint management
Swiss medical device manufacturer Synthes has received a warning letter from U.S. regulators taking issue with the company’s management of…
Read More » -
Spine
Synthes Takes on 3 Former Sales Reps, Stryker in Loyalties Case Featured
Synthes, a Swiss spine device company currently in the middle of being acquired by Johnson & Johnson, recently filed suit…
Read More » -
Spinal Kinetics Wins in Synthes Patent Suit
SUNNYVALE, CA, Dec 13, 2011 (MARKETWIRE via COMTEX) — Spinal Kinetics, the designer and manufacturer of the innovative M6(R) Artificial…
Read More » -
Biologics
Update: Two ex-Synthes executives, Michael Huggins and Thomas Higgins, get 9 months in prison
UPDATE 3 p.m.: At about 2:45 p.m., Brent Gurney, the attorney for Richard Bohner, collapsed while standing at a lectern…
Read More » -
Biologics
Ex-Synthes Executives Scheduled to be Sentenced Today
One doctor employed by the medical device manufacturer Synthes, Inc., called it “human experimentation.” That doctor was fired. Four of…
Read More » -
Spine
EU Opens In-Depth Probe Into Johnson & Johnson Deal for Synthes
Nov. 4 (Bloomberg) — European Union antitrust regulators opened an in-depth probe into Johnson & Johnson’s proposed acquisition of Synthes…
Read More » -
Biologics
Prosecutors want jail time for execs
Former executives at medical products company Synthes would face jail time under sentencing guidelines expected to be proposed this week by…
Read More » -
Recon
Zimmer, Stryker May Seek Orthopedic Purchases to Keep Pace After J&J Deal
Johnson & Johnson’s newfound dominance of the orthopedic-device market, cemented by its $21.3 billion acquisition of Synthes Inc. (SYST), may drive…
Read More » -
Extremities
Johnson & Johnson CFO: Synthes deal doesn’t mean we’re done
Johnson & Johnson (NYSE:JNJ) may have just dropped a cool $21.3 billion to acquire Synthes (SWX:SYST.VX), but it doesn’t mean…
Read More » -
Extremities
Johnson & Johnson Taps Its War Chest, Pays $21.3B For Synthes
Johnson & Johnsontapped its war chest andagreed to buy the Swiss-American orthopedic device maker Synthes for $21.3 billion in cash…
Read More » -
Recon
Synthes confirms talks with JNJ
West Chester (PA), USA, April 18, 2011 In response to market speculation, Synthes, Inc. (SIX Swiss Exchange: SYST.VX),…
Read More » -
Synthes buys surgical tool company Anspach Effort
Synthes Inc. said Monday it has acquired The Anspach Effort Inc., a maker of high-speed surgical power tools. Terms of the…
Read More » -
UPDATE 2-Synthes sees low growth in 2010 after weak Q4
ZURICH, Feb 17 (Reuters) – Swiss medical device maker Synthes Inc (SYST.VX) said revenue growth is likely to remain in…
Read More » -
FDA says recalled Synthes devices are health hazard
ZURICH (Reuters) – The U.S. Food and Drug Administration has classified a recall of Synthes’ Synex II Central Body components…
Read More »